rss
J Neurol Neurosurg Psychiatry doi:10.1136/jnnp.2010.231613
  • Research paper

The perfect crime? CCSVI not leaving a trace in MS

Table 1

Clinical and demographic data of multiple sclerosis (MS) patients and healthy control subjects

Demographics Relapsing-remitting MS Secondary progressive MS All MS Controls
Subjects, no 17 3 20 20
Mean age, years (SD) 40.3 (13.9) 55.3 (9.3) 42.2 (13.3) 34.3 (11.0)
Sex male/female 5/12 2/1 7/13 10/10
Extended Disability Status Scale range/median/SD 0–4.5/3/1.3 4–6.5/6/1.3 0–6.5/3/1.7 /
Disease duration, years, range/mean/SD 1–35/11.2/10.2 11–36/23/12.5 1–36/13.1/11.1 /
Patients on medication, no 15/17 3/3 18/20 /
Patients on natalizumab, no/total 10/15 0 10/20 /
Relapses*, no, range/mean/SD 0–4/0.9/1.1 0 0–4/0.9/1.1 /
CSF positive, no/total 16/17 3/3 19/20 /
MRI positive, no/total 17/17 3/3 20/20 /
  • * In the previous 12 months.

  • Positive oligoclonal bands.

  • Cerebral MRI indicative for MS according to Barkhof et al.14

Podcasts
Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article